10) . Certain tumor variants lacking the novel antigens can grow progressively in immunocompetent hosts, suggesting that these molecules may play an important role in the biology of this tumor (11) . The isolation of the genes encoding the novel antigens, termed A 149, A 166, and A216, has been previously described (12) . Since these genes account for several of the polymorphic restriction fragments observed in the class I genes of 1591 when compared with C3H by genomic Southern blot analysis, we have previously proposed (12) that these genes were generated by recombination events among the endogenous class I genes of C3H . To determine the origin of these novel genes and the role of their products in the neoplastic process, it is necessary to characterize their structure and examine the extent to which each molecule can be recognized by the immune system .
In this report, we present the complete DNA sequence of these three novel class I genes, and describe in detail the recognition of their products by alloreactive and tumor-specific CTL . We find that these genes are highly homologous to those of previously characterized class I antigens, such as H-2Kk (13) and H-2L`' (14) , and that the structural conservation seen among these gene products is reflected in their functional homology as well . Since the class I diversification events by which these novel tumor genes were generated probably parallel events that occur in the germline, the identification and analysis of the parental C3H genes from which they were derived might be relevant to the study of class I evolution . Furthermore, the discrete pattern of structural and functional homology seen among A 149, A 166, and H-2 L' suggests that functional analysis of these novel H-2L products should provide significant insight not only into the role that these molecules played in the progression of the 1591 tumor, but also into the structural basis of T cell recognition .
Materials and Methods
Materials. Restriction endonucleases were obtained from New England Biolabs, Beverly, MA. Escherichia coli DNA polymerase Klenow fragment was obtained from Boehringer Mannheim Biochemicals, Indianapolis, IN. E. coli strain JM103, phage MI3mpl8, and mp19 were the gift of Dr. Chuck Staben (Department of Biochemistry, University of California, Berkeley) . Oligonucleotide primers homologous to class I sequence were synthesized by Lynn Williams at the University of Southern California Medical Center, and by Bruce Malcolm at the Department of Biochemistry, University of California, Berkeley .
Cell Lines and Animals . The C3H origin of the 1591 tumor has been previously documented (9, 10, 12) . The 1591 tumor and the 28-tumor variant (9) were the kind gift of Dr. Hans Schreiber (Department of Pathology, University of Chicago) . L cell transfectants were generated previously (12) . Mice were bred and maintained in the colony at the University of Texas Health Science Center, Dallas . DNA Sequence Analysis . The genes were sequenced in parallel by the dideoxy chain termination method (15) using a set of 40 synthetic oligonucleotide primers complementary to class I sequences . We chose primers that hybridize at 200-250 by intervals in both orientations, according to the DNA sequence of the H-2D d gene (16) . Up to 350 by were read per sequencing reaction on 5% urea/7% polyacrylamide gels.
Generation of Cytotoxic T Lymphocytes . To generate CTL activity against the 1591 tumor or L cells transfected with tumor-derived class I genes, (C3H x dm2)F, animals were inoculated intraperitoneally with 107 tumor or transfected L cells .^-3 wk later, spleens were removed from the primed animals and these cells were cultured in vitro with either x-irradiated (3,000 rad) tumor cells, L cells transfected with the tumor genes, or 
Results
Summary of the class I specificities displayed on the UV tumor, 1591 . Specificities and tentative domain assignments of antibodies 34-1-2, 34-4-20, 30-5-7, and 28-14-8 were previously determined (19) (20) (21) (22) . CP28 and CP3F4 are 1591-specific mAbs (9) , which have been mapped to the a2 domain (M . McMillan, University of Southern California, Medical Center, personal communication). Reactivities were previously measured by cell-binding RIA of 1591 tumor cells or L cell transfectants (12) . 34-1-2 reactivities are unpublished data (H . Stauss). +, strong reactivity ; ±, weak reactivity ; -, no reactivity .
BALB/c spleen cells . 5 d later, the cultures were tested for cytolytic activity against "Crlabeled target cells . CTL clones were generated as described previously (17) . All of the clones are specific for H-2L' and were derived from either CBA anti-A .A L or (C3H X dm2)F l anti-BALB/c cultures . The clones are maintained in the presence of rat Con A supernatant and irradiated spleen feeder cells .
Target Cells. The target cells consisted of either L cells expressing transfected class I genes or 1591 tumor cells . Targets were labeled with "Cr and between 2 X 10'-10' cells were added to wells containing effector cells . After 4 h of incubation, the culture supernatants were tested for radioactivity . Specific release = (experimental releasespontaneous release)/maximum release .
CTL Competition Assay. This assay has been described previously (18) . Briefly, varying numbers of unlabeled L or tumor cells were added to a mixture of effector and labeled target cells in the cytolytic assay . Data are presented as : % inhibition = [ 1 -(specific release in the absence of inhibitor cells -specific release in the presence of inhibitor cells)/specific release in the absence of inhibitor cells] X 100 .
Expression of the Novel Antigens by L Cell Transfectants, and Serological Characterization of Novel Gene Products. The 1591 tumor is recognized by several alloand tumor-specific mAb unreactive with products expressed on normal C3H tissues (9, 10) . As summarized in Table I , these include the syngeneic anti-1591 mAbs CP28 (9) and CP3F4 (9) and the H-2L crossreactive antibodies 34-1-2 (19, 20) , 30-5-7 (19, 21) , and 28-14-8 (19, 21) . Genomic X clones A149, A166, and A216 were isolated from a 1591 genomic library on the basis of crosshybridization to the class I-specific cDNA clone, pH-211a, and identified as encoding the 1591 tumor-specific epitopes by transfection into C3H L cells and RIA screening of transfectants with a panel of tumor-reactive antibodies, as previously described (12) . The serological reactivities of the individual novel class I gene products, as Genes were sequenced in parallel using either the M13 universal primer or one of a set of class I crosshybridizing primers synthesized according to the sequences of H-2D' (16) or H-2K°(13) (P-40, C4243) . Primers are numbered according to the H-2D' sequence. P primers give sequence in the published orientation . C primers give complementary sequence . The following primers were used : P-40, P249, P437, P493, P708, P989, P1210, P1509, P1810,  P1964, P2476, P2639, P2975, P3290, P3494, P3999, C286, C552, C580, C761, C1034,  C1240, C1540, C1803, C2000, C2222, C2400, C2727, C3066, C3226, C3390, C3580,  C3760, C3983, and C4243. well as other related class I antigens, are summarized in Table I . All of the alloand tumor-specific class I serological reactivities seen on the 1591 tumor can be accounted for by the reactivities of the three individual novel class I antigens .
We have described two of these antigens as H-21--like because they are recognized by at least two mAbs crossreactive with the H-2L d antigen from BALB/c . A149, A166, and H-2L d share the determinants recognized by the mAbs 28-14-8 and 34-1-2 . In addition, both A166 and H-2L d are recognized by the antibody 30-5-7. The antibody 34-4-20 (22) , on the other hand, recognizes neither H-2L-like tumor antigen, although it recognizes both H-2Ld and H-2Dd . The A166-specific mAb, CP3F4, crossreacts with H-2Kd, but it recognizes neither A149 nor H-2Ld transfectants. The product of the A216 gene is identified by the anti-1591 mAb CP28 . In addition, expression of the A216 and A149 products in BALB/c 3T3 cells indicates that these C31-derived antigens retain several H-2' haplotype reactivities (data not shown) . DNA Sequence of the Novel Class I Genes Derived from the 1591 Tumor. The nucleotide sequence of genes A149, A166, A216, and the H-2Ld clone X27 .5 (14) were determined using the sequencing strategy described in Fig. 1 . Briefly, 1-3-kb unique restriction fragments diagnostic for each of the X clones were subcloned into the polylinker of M 13mp 18 or mp 19 . Templates derived from these subclones were sequenced in parallel by the dideoxy-chain termination method, using a set of 40 crosshybridizing synthetic oligonucleotides as primers (see Fig. 1 ) . Sequence differences between the genes could thus be confirmed directly on the same gel.
The DNA sequences of the three novel class I genes are quite homologous to (14), and H-2Db (23), and A216 by comparison with H-2Kk (13) . All three genes appear to comprise eight exons, the first encoding the leader peptide; three exons encoding the three external domains, al, a2, and a3 ; an exon encoding the hydrophobic transmembrane region ; and three exons accounting for the cytoplasmic domain of the antigen and the 3'-untranslated trailer sequence . All splice junctions assigned for H-2Ld (14) and H-2K k (13) appear to be represented. Like H-2Ld, A149 and A166 each contain three attachment sites for N-linked glycosylation ; like H-2Kk, A216 contains two. The single amino acid substitution of a leucine for a cysteine at residue 121 in the a2 of A 166, does not involve a cysteine normally involved in a disulfide bond . Since the A216 gene encodes a product recognized by mAbs crossreactive with H-2Kk, and since the A216-specific antibody CP28 crossreacts with H-2Dd, we have compared the DNA sequence of A216 with the published sequences of these class I genes. The overall homology between A216 and H-2Dd is comparable to that seen between other H-2 genes, such as H-2Ld or H-2Dd . Comparison of A216 and the H-2K' from AKR revealed similar homology of 85-90% throughout the 5' ends of these genes. Striking homology of >99%, however, was seen between the 3' ends of these two genes, from a point^-300 by 5' of exon 4, and continuing for 1,800 by into 3'-untranslated sequences. A 1-kb polymorphic Pst I restriction fragment not found in the C3H genome (12) maps within this region, suggesting that the 3' end of this gene was generated by a recombination event between two class I genes homologous to H-2Kk in this region . Preliminary screening of the class I genes from a normal C3H library by restriction mapping and with A216-specific oligonucleotide probes has identified several potential 3' parents, including H-2Kk (S . Watts, University of California, Berkeley, unpublished results) . Thus it is possible that H-2K'`is itself a parent, and that the minimal degree of divergence, i.e., eight point differences and two small clustered changes, seen between the 3' coding region of A216 and the H2Kk sequence might reflect sequencing differences or strain substitutions between the C3H and AKR H-2K alleles. Further sequence analysis of the normal C3H genes will be required to unambiguously identify the parental genes. Since the molecules encoded by A 149 and A 166 share serological determinants with each other and H-2Ld, we sequenced these genes in parallel . The complete and revised sequence of H-2Ld, as well as the sequences of the two C3H-derived H-2L-like genes, is presented in Fig. 2 . The DNA sequences of the H-2L-like tumor genes are nearly identical to each other, to H-2L d, and to the corresponding regions of an H-2Db cDNA clone (23) for 3,000 by from within the large intron until the end of the 166 clone (Fig. 2) . Within this region A149 is identical to H-2Ld, and A166 exhibits only two bases that are polymorphic. The only region of these genes for which <99.9% homology is found is within the exons encoding the first and second external domains, a l and a2, which are believed to be the regions primarily responsible for T cell recognition (24) . Within the first 1,000 by of these genes, A149 and A166 are 99.1 and 98 .6% homologous to H-2L d, respectively .
The two Pst I sites defining one of the polymorphic restriction fragments seen in A149 and A166, but not in the C3H genome, map within the region of near identity to H-2Ld at positions 3009 and 4047, suggesting that these H-2L coding sequences exist in unexpressed form within the C3H MHC requiring a specific recombination event to be activated. Since both A149 and A166 contain the same polymorphic Pst I fragment, it is possible that they were generated by duplication and divergence from a single parental recombinant gene . However, analysis of 5'-flanking sequences and restriction enzyme site polymorphisms indicate that these two genes are derived from different 5' parents (data not shown) .
Structural Basis for Conserved Serological Determinants on Novel H-2L-like Antigens . The data concerning the serological recognition of these novel gene products can be analyzed in light of the predicted amino acid sequences (Figs .  2-4) . The identity between the three L-like antigens in the a3 domain, and the extreme homology between the antigens in the a l domain are consistent with the shared reactivities with 28-14-8 and 34-1-2, which have been shown to map to the a3 and al domains, respectively (20, 21) . Since 34-1-2 binds A166 with higher affinity than either A149 or H-2L d (Table I) , it is intriguing that three of the five amino acid substitutions that A166 bears in the al domain with respect to H-2Ld, render A166 more homologous to either H-2K d (25) or H-2Dd, both of which are strongly reactive with 34-1-2 .
The lack of reactivity with the a2-specific antibody, 34 this antibody to the C-terminal two-thirds of the a2 domain. However, it is likely that other regions will be involved in the formation of a functional antigenic epitope, since A149, which is not 30-5-7-reactive, is quite conserved with H-2L d and A 166, both of which are recognized . For example, the amino acid substitution of a tryptophan for a glycine at position 107 of A149 might somehow interfere with the formation of a functional determinant by the rest of the domain. Oligonucleotide-directed mutagenesis experiments should help resolve this issue. The tumor-specific mAb CP3F4 recognizes the antigens A166 and H-2K'. Since the only amino acid residues unique to these molecules are a serine and an alanine at positions 77 and 81 in the al domain, it is impossible to identify any specific set of amino acids influencing the epitope recognized by this antibody without additional mutagenesis experiments. Similarly, although the tumorspecific antibody CP28 recognizes both A216 and H-2Dd (9), the available data do not reveal any obvious pattern of unique structural homology between these molecules.
Recognition of Novel Antigens by Allospecific CTL. The 1591 tumor is highly immunogenic and induces a strong CTL response when transplanted into normal syngeneic mice (27, 28) . To distinguish the components of the CTL response directed against each of the novel class I antigens, we have tested L cells transfected with the three individual genes for their ability to function as targets for anti-1591 CTL. Since primary in vitro anti-1591 responses could not be detected (data not shown), CTL populations directed against the tumor were generated by immunization of (C3H X H-2dm2)F, mice with 107 1591 tumor cells. 3 wk later the spleen cells of these mice were placed in culture with irradiated 1591 stimulator cells. After a 5-d culture period, the effector cells were tested against 5'Cr-labeled L cell targets, as well as 1591 and the 1591 (28-) variant, selected in vitro for the loss of the three novel class I products (11) . Both 1591 and L cells expressing each of the novel gene products were recognized and effectively lysed by the anti-1591 CTL (Fig. 5a ), as were BALB/c 3T3 cells transfected with the A216 gene (data not shown) . L cells expressing the H2Ld antigen were also recognized, but to a lesser extent . These data indicate that all three novel class 1 products function as targets of the CTL generated against the tumor. In addition, residual reactivity can be detected against the 28 -tumor variant lacking these novel antigens (reference 9, Fig. 5 a) . This residual reactivity probably reflects the recognition of antigenic molecules distinct from the novel class I products on this tumor . Wortzel et al . (28) have shown that 1591 expresses at least four genetically distinguishable sets of novel tumor antigens, termed A, B, C, and D, as defined by cloned CTL. Three of these antigens, B, C, and D, remain on the 28 -tumor variant (9) , and are therefore not related to the novel class I molecules discussed in this report . However, given that none of the tumorreactive mAbs block the anti-A CTL (29), it is not yet possible to determine the relationship between any of the novel class I antigens and the A target molecule .
Since some anti-1591 CTL activity was directed towards H-2L' (27 .5 cells) (Fig . 5a) ; we cultured spleen cells from the 1591-immunized (CM X H-2d,2 )F, mice with BALB/c (H-2d) spleen cells. H-2d,2 is a meiotic mutant of BALB/c that lacks the H-2L d antigen . Therefore, this procedure should generate a primary anti-H-2Ld response, as well as amplify any anti-H-2L' crossreactive component that arose from the priming with 1591 cells. The effector cells generated lysed 1591 tumor cells, L cells expressing the A149 antigen, and H2Ld (Fig . 5b) . L cells expressing the A166 product were also killed, but much less efficiently . In contrast to primed cells challenged in vitro with 1591 cells (Fig . 5a ), effector cells challenged in vitro with BALB/c spleen cells did not lyse target cells expressing A216 or the 28 -variant tumor line . This indicates that the A216 antigen does not cross react with H-2Ld at the T cell level. It is likely that the differential recognition of A149 and A166 by the anti-H-2L CTL reflects some of the five amino acid differences that exist between the a 1 domains of these molecules .
To further study the relationships among H-2Ld , A 149, and A 166, we tested bulk-cultured anti-H-2Ld CTL, as well as several anti-H-2Ld CTL clones, against these target cells (Table 11 ) . (C3H X dm2)FI anti-BALB/c (anti-H-2L) CTL displayed lytic activity against H-2Ld and A149 transfectants, but not L cells transfected with Al 66 or A216 (Fig . 6, left) . Activity was also noted against the 1591 target cells (Fig . 6, right) , but not the 28 -variant. Four out of seven anti-H-2L d clones recognized A 149 transfectants, while none lysed A166 transfectants (Table II) . Taken together with the data presented in Fig. 5b , these results indicate that A149 extensively crossreacts with H-2Ld at the T cell level, while A166 is much less crossreactive. To further show that the A149 molecule, either expressed on the transfected L cells or the 1591 tumor, crossreacts with allospecific anti-H-2Ld CTL, we tested the ability of A149-expressing cells to block the cytolytic activity of an anti-H-2Ld CTL clone, 1-1313 .17 . This clone lysed H-2Ld (27 .5) and A149 transfectants, as well as 1591 cells (Fig . 7, a-c) . The lysis of any of these three targets could be blocked by adding an excess of 27 .5, A149, or 1591 inhibitor cells. No inhibition occurred when Ltk-or the 28 -variant inhibitor cells were added, as expected .
Thus, the above data show that the novel H-21--like antigens expressed on the tumor can serve as targets for alloreactive anti-H-2Ld CTL . In addition, we wished to determine whether these antigens could also function as restriction elements for antigen-specific CTL. Therefore, we analyzed the reactivity of H2Ld-restricted anti-vesicular stomatitis virus (VSV)' CTL with VSV-infected L cells expressing the class I molecules from the tumor . The H-21--like A149 antigen can, in fact, function as a restriction element for these H-2Ld-restricted CTL (Fig . 8, a-c) . No lytic activity against A216 or A166 transfectants was shown (Fig . 8c) . Thus the heirarchy of recognition of the tumor antigens by the bulk and cloned anti-H-2Ld alloreactive CTL was comparable to that of the H2Ld-restricted CTL, suggesting perhaps that the same class I structures recognized by allospecific CTL are involved in the function of class I restriction elements .
' Abbreviation used in this paper: VSV, vesicular stomatitis virus. 
Discussion
In addition to the normal complement of H-2K k and H-211'`, the UV-induced C3H (H-2 k) fibrosarcoma, 1591, expresses at least three novel class I antigens (12) . Previous characterization of 1591 and 1591 tumor variants suggests that these novel class I antigens might function as the primary targets of a CTL response in normal histocompatible mice (9, 28) . Since the loss of these products correlates with the ability of certain variants of this normally nonmetastatic tumor to escape immune rejection and progress to metastasis in immunocompetent hosts (9, 11) , it is clear that they play an essential role in limiting tumor growth in the transplant situation. It is not obvious, however, what effect expression of these products exerted on the progression of the tumor in its original UV-irradiated host . While U V irradiation appears to induce a specific suppression of the ability of normal mice to mount an immune response against UV-induced tumors (5, 28) , the immune elimination of other non-UV-induced tumors remains relatively unimpaired (30, 31) . Most UV-tumors express unique tumor specific-antigens (9, 31) , but the biochemical nature of these antigens and their relationship, if any, to UV-specific suppression remain obscure. The 1591 fibrosarcoma is the first UV-induced tumor for which a molecular description of any tumor antigens is available.
Before it is possible to define the specific immunobiological interactions that the novel class I antigens might mediate when expressed on the developing tumor, we believe that it is necessary to define the functional properties of these molecules in the context of a competent immune system . It is also essential to define the molecular origin of these antigens to determine whether their expression is, for example, a general response to the UV treatment.
To this end we have identified (12) the genes encoding the three novel class I antigens expressed on the 1591 tumor, determined the DNA sequences of the genes and the amino acid sequences of their predicted products, and characterized the functional recognition of these molecules on the 1591 tumor and on L cells transfected with the individual novel tumor genes. The three novel class I genes, A 149, A 166, and A216, encode polypeptides that are highly homologous to, yet distinct from, previously characterized class I antigens . Since the 1591 tumor does indeed appear to be derived from C3H (9, 12) , and the novel genes account for several of the polymorphic restriction fragments observed in genomic Southern blots comparing the class I genes of 1591 with those of normal C3H tissue (12) , these unique genes may have been generated by multiple recombination events among the endogenous class I genes of C3H .
In support of this hypothesis, the A216 antigen is extremely homologous to the AKR H-2K' antigen throughout its C-terminal domain . The 5'-flanking information encoded on the A clone containing this gene suggests strongly that the 5' coding information of this gene is derived from the equivalent of one of the cluster 8 genes defined from the BALB/c cosmid library (reference 32 and S. Watts, University of California, Berkeley, unpublished results) . The A216 X clone not only contains a fragment of a second class I gene in a head-to-head orientation, but hybridizes to a low copy probe specific for this cluster (31) . Furthermore, this clone contains a 7 .7-kb polymorphic Hind III fragment defined as representative of C3H (31), consistent with the C3H origin of this gene . Although the H-2K k gene may serve as a 3' parent, the complete description of the events by which A216 was generated awaits further DNA sequence comparison with the appropriate C3H loci .
One of the most intriguing features of this tumor is that 1591 expresses two distinct, highly homologous, and immunologically crossreactive class I antigens . A149 and A166 are >98% homologous to each other and to the H-2Ld antigen from BALB/c . The genes encoding these three antigens are nearly identical for 2,000 by containing the exons encoding the third external domain, a3, the transmembrane domain, and the cytoplasmic domain . Unique sequences within the 5' ends of the genes account for the discrete functional differences observed between their products . Since a polymorphic Pst I fragment not found in C3H is contained within this region of near identity, it is possible that A 149 and A 166 were derived by duplication of a recombinant precursor gene, followed by additional recombination events to generate the discrete differences between the two tumor genes. Alternatively, the polymorphic 1 .0-kb Pst I fragments found in both A 149 and A 166 might have been generated independently by comparable recombination events involving two highly conserved parental genes. Additional polymorphic restriction fragments map to the 5' end of the gene, suggesting that multiple recombination events were required to generate each of these novel genes (data not shown) . Identification and DNA sequence analysis of all of the class I genes involved in these complex recombination events will probably be necessary to define the precise recombinational pathway by which these novel genes were generated.
The extensive sequence homologies observed among A 149, A 166, and H-2L' are also shared with the 3' coding region of the H-2D b gene . Such unprecedented sequence conservation between class I genes from three different haplotypes is remarkable, and argues for an allelic relationship between these three sets of genes (33) . In support of this hypothesis, a 5' flanking probe derived from A 149 crosshybridizes to H-2L d, and detects several class I genes from a normal C3H library, which map to the D end of the H-2 (e . g., H-2D'`). Thus, although C3H is not believed to express H-2L locus information, conserved H-2L coding sequences may exist in an unexpressed configuration within the appropriate region of the MHC.
The extreme structural conservation observed among A149, A166, and H-2L d is reflected by significant functional homology . The three antigens share both public and private class I antigenic determinants, and most of the antigenic differences that have been observed among these molecules appear to correlate with discrete sequence substitutions. Previously, studies involving the serological characterization of exon-shuffled class I gene products have succeeded in localizing the structures recognized by several different allospecific mAb to individual protein domains (21, (34) (35) (36) (37) . Unfortunately, attempts to correlate such serological determinants with specific sets of amino acids have been complicated by the comparison of class I products that differ at multiple amino acid residues (38) . However, given the ability of antibodies directed against discrete peptides to recognize the native conformation of a protein (39) , it is essential to determine whether specific alloantibodies against H-2 react with conformational determinants, or whether it is possible to identify specific coding sequences that can function as independent epitopes .
While both A149 and A166 molecules are closely related to H-21Ld, both by sequence and serological criteria, only the former molecule crossreacts exten-sively with H-2L' at the T cell level. Thus, anti-1591 CTL react against H-2L', A149, A166, and A216, while anti-H-2Ld CTL crossreact primarily with A 149. However, a distinct population of A166 crossreactive CTL could be shown by challenging the spleen cells from tumor immune animals in vitro with H-21-d. A149 and A166 differ from H-2L d at 6 and 8 amino acid residues, respectively, in the a2 domain . Four of the changes are shared by both A 149 and A 166, and the additional unique changes found in A 166 are no more different, with respect to charge or side-chain bulk, than those seen in A149. In contrast, A 166 has 5 amino acid changes in the al domain while A149 has none . Thus, these results could indicate that the vast majority of anti-H-21-d CTL are controlled by determinants mapping to the al domain . This is surprising, however, in light of previous results that mapped some H-2Ld CTL determinants to the a2 domain . Specifically, Murre et al . (37) have observed that a domain shuffled molecule that contained the al of H-2Dd and the a2 of H-2L' retained anti-H-2Ld CTL determinants . We (J . Forman, unpublished data) have noted that anti-H-2Ld CTL also readily recognize the H-2d "' molecule, which has H-2Ld sequences only in the carboxy-terminal end of the a2 domain, but H-2Dd sequences in the a 1 and the proximal half of the a2 . Perhaps these observations can be reconciled with the data discussed in this report by postulating that specific intramolecular interactions with a1 structures are required to impart a recognizable conformation on a2-encoded determinants . Amino acid substitutions found in the a 1 of A166 might somehow interfere with these conformational interactions . Such interactions might not be obvious from the analysis of the shuffled or dm l molecules described above if the H-2Dd al domain was itself compatible with the a2 of Ld . This hypothesis can be tested by generating mutant A 166 molecules in vitro, in which A166 residues are replaced with H-2L d and Dd sequences.
Conformational interactions between class I domains have been implicated in previous studies involving the H-2K b series of class I mutants (40, 41) where one to three amino acid changes in either the al or a2 domains usually result in the loss of most of the CTL epitopes . Further evidence for conformational interactions and the requirement for domain compatibility comes from studies involving the shuffling of exons that encode the al and a2 domains of class I molecules (34) (35) (36) . In these studies it was found that virtually all of the CTL epitopes characteristic of the native molecules are absent from the hybrid molecules.
Detailed study of the structural bases of these conformational interactions might be uniquely accessible in the 1591/H-2Ld system for several reasons: (a) the structural differences that exist between A149, A166, and H-2Ld are quite discrete and can be easily manipulated by oligonucleotide directed mutagenesis; (b) all three antigens seem able to evoke a CTL response ; (c) A149 and A166 each crossreact to some extent with H-2Ld with respect to both CTL and serological reagents ; (d) discrete changes in crossreactivity will probably be observed after in vitro mutagenesis; and (e) H-2Ld has already been extensively characterized as a T cell target (17, 18, 35) .
The crossreactivity of A 149 with H-2L d was also noted with regard to antigenspecific CTL. Thus, $DF, anti-VSV CTL, restricted to H-2L d, also recognize VSV antigens in association with A149 . These data indicate that the tumor not only expresses a molecule that can function in the restriction of virus-specific CTL, but also that the functional homology of A 149 to H-2Ld involves determinants recognized by both allospecific and H-2-restricted CTL .
Taken together, our present results indicate that all three novel class I antigens expressed on 1591 can function as potential target structures for the immune destruction of the transplanted tumor in histocompatible hosts . Of course, the immunogenicity of any one of these molecules could depend upon its relative level of expression on the surface of the tumor cell, as well as the immunological status and specific MHC background of the host . It is also difficult to predict the precise effects of the expression of the two highly homologous, but distinct, H-21--like antigens . Clearly, this tumor could progress in the autochthonous host despite its extreme immunogenicity, and it is quite possible that the expression of these novel antigens was somehow related to the UV-induced immune suppression operative during tumor progression . Further immunobiological studies involving tumor variants and class I transfectants transplanted into UV-irradiated and normal hosts may elucidate the precise effect each of these molecules might mediate during tumor progression .
Summary
The UV-induced, C3H fibrosarcoma, 1591, expresses at least three unique MHC class I antigens not found on normal C3H tissue . Here we report the complete DNA sequence of the three novel class I genes encoding these molecules, and describe in detail the recognition of the individual products by tumorreactive and allospecific CTL . Remarkably, although C3H does not appear to express H-2L locus information, this C3H tumor expresses two distinct antigens, termed A 149 and A 166, which are extremely homologous to each other and to the H-212 antigen from BALB/c . The gene encoding the third novel class I antigen from 1591, A216, is quite homologous to H-2Kk throughout its 3' end . Since all three of these genes account for polymorphic restriction fragments not found in C3H, it is likely that they were derived by recombination from the endogenous class I genes of C3H . The DNA sequence homology of A 149, Al 66, and H-2L d is especially significant given the functional conservation observed between the products of these genes . Limited sequence substitutions appear to correlate with some of the discrete serological differences observed between these molecules . In addition, both A149 and A166 crossreact, but to differing extents, with H-2L d at the level of T cell recognition . Our results are consistent with the view that CTL recognize complex conformational determinants on class I molecules, but extend previous observations by comparing a set of antigens with discrete and overlapping structural and functional differences .
